Home > Balance Sheet > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹1.34 Cr₹0.90 Cr₹1.00 Cr₹1.10 Cr₹0.04 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of BALAXI PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of BALAXI PHARMACEUTICALS is ₹1.34 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹1.34 Cr
Mar2025₹0.90 Cr
Mar2024₹1.00 Cr
Mar2023₹1.10 Cr
Mar2022₹0.04 Cr

How is Deferred Tax Assets / Liabilities of BALAXI PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹1.34 Cr
48.33
Mar2025 ₹0.90 Cr
-9.55
Mar2024 ₹1.00 Cr
-9.63
Mar2023 ₹1.10 Cr
2,723.08
Mar2022 ₹0.04 Cr -

Compare Deferred Tax Assets / Liabilities of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹115.4 Cr -5.3% -9.6% -49.9% Stock Analytics
ADANI ENTERPRISES ₹336,806.0 Cr -7.4% -16.7% 2.6% Stock Analytics
ADITYA INFOTECH ₹46,593.3 Cr -6.5% 4.3% 181.4% Stock Analytics
AEGIS LOGISTICS ₹43,876.8 Cr -8.5% -12.2% 62.3% Stock Analytics
PREMIER ENERGIES ₹40,038.5 Cr -2.5% -3.1% -19% Stock Analytics
REDINGTON ₹28,097.0 Cr -6.3% -12.4% 35% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-5.3%

-9.6%

-49.9%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses